Antivinculin antibodies in systemic sclerosis: Associations with slow gastric transit and extra-intestinal clinical phenotype
Antivinculin Antibodies in Systemic Sclerosis: AssociationsWith Slow Gastric Transit and Extraintestinal ClinicalPhenotype
Similar Posts
Digital disease management program reduces chronic gastrointestinal symptoms among racially and socially vulnerable populations
Digital disease management program reduces chronic gastrointestinal symptoms among racially and socially vulnerable populations
Bravata, Liu, Colosimo, Bullock, Commons, PimentelSeptember 15, 2024
Improvements in digestive symptoms after participation in an app-based digestive disease management program
Improvements in digestive symptoms after participation in an app-based digestive disease management program
Bravata, Liu, Colosimo, Bullock, Commons, PimentelSeptember 10, 2024
Improvements in digestive symptoms after participation in a digital digestive chronic care program
Improvements in digestive symptoms after participation in a digital digestive chronic care program
Hau Liu, MD, MBA, MPHOctober 15, 2023
